. Effect of pre-dosing verapamil at 6.25 mg/kg (the human equivalent dose) once daily for 8 days on the pharmacokinetic parameters of rifampicin (RIF) dosed orally (p.o.) once on day 8 at 10 mg/kg. Values are means ± SD (n=8). 
Description of the results:
Recently it was shown that the promoter of the transcription factor gene clgR (part of the cell envelope stress-sensing Psp system of Mycobacterium tuberculosis (2)), is induced by various membrane inserting agents, including SDS (2) and a novel amphiphilic indole based lead compound 74a (1). To provide further evidence for membrane stress sensitivity of pclgR activity we tested another recently identified membrane inserting lead compound, the xanthone derivative AM0016 (3) and again observed dose dependent induction of pclgR promoter activity. In contrast, drugs not interfering with membrane integrity such as the ATP synthase inhibitor bedaquiline or the gyrase inhibitor ciprofloxacin did not cause increased activity of the promoter. Fig. S4 shows that verapamil treatment also induced pclgR activity in a dose dependant manner, similar to the membrane inserting lead compounds 74a and AM0016, consistent with a membrane integrity disrupting function of verapamil. 
